Final answer:
A client on bumetanide, a loop diuretic, is most likely to develop hypokalemia. It occurs due to the increased excretion of potassium in the urine as a result of the drug's effects on the sodium and chloride reabsorption in the loop of Henle. the correct answer is c) Hypokalemia.
Step-by-step explanation:
A client receiving bumetanide, which is a diuretic, should be aware of symptoms associated with electrolyte imbalances, particularly hypokalemia. Bumetanide acts on the loop of Henle, inhibiting the reabsorption of sodium (Na+) and chloride (Cl-); this increases urine production and can lead to a significant loss of potassium. Hypokalemia manifests as an abnormally decreased blood level of potassium, which may present symptoms such as muscular weakness, cramps, and abnormal heart rhythms.
Loop diuretics like bumetanide may cause a variety of electrolyte imbalances, but the client is most likely to experience hypokalemia due to the loss of potassium, overshadowing other conditions such as hypernatremia, hypercalcemia, or hypophosphatemia. It is essential that patients monitor for signs of low potassium and report any such symptoms to their healthcare provider promptly.
The client receiving bumetanide is most likely to experience hypokalemia, due to the loss of potassium caused by the drug's action on the loop of Henle.